<DOC>
	<DOCNO>NCT02686047</DOCNO>
	<brief_summary>Viscosupplementation widely use treatment knee osteoarthritis ( OA ) . There well control trial compare one injection regimen HA treatment knee OA . The purpose study compare efficacy safety one intraarticular injection novel crosslinked HA ( HYAJOINT Plus ) Synvisc-One treatment knee OA .</brief_summary>
	<brief_title>Comparing One Intraarticular Injection Novel HYAJOINT Plus With Synvisc-One Treatment Knee OA</brief_title>
	<detailed_description>In prospective , randomize control , double-blind trial 6-month follow , patient knee OA ( Kellgren-Lawrence grade 2 3 ) randomize receive one intraarticular injection 3 ml HYAJOINT Plus ( microbial ferment HA , 20 mg/ml ) ( N=66 ) 6 ml Synvisc-One ( avian derive HA , 8 mg/ml ) ( N=66 ) . The primary outcome change visual analog scale ( VAS ) pain ( 0-100mm ) 6 month . Secondary outcome include The Western Ontario McMaster Universities Osteoarthritis Index ( WOMAC ) , Lequesne index , Timed Up-and-Go test ( TUG ) , single leg stance test ( SLS ) , use rescue analgesic patient satisfaction .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<mesh_term>Hylan</mesh_term>
	<criteria>symptomatic knee OA pain least 6 month , despite conservative treatment analgesic , NSAIDs and/or physical therapy average pain knee movement 30 mm great 100mm VAS grade 2 3 knee OA accord KellgrenLawrence grading system base radiograph take within previous 6 month Radiological evidence bilateral knee OA accept global pain VAS contralateral knee le 30 mm . previous orthopedic surgery spine low limb disable OA either hip foot knee instability , clinical apparent joint effusion mark valgus/varus deformity know allergy avian protein HA product woman ascertain suspected pregnancy lactate intraarticular injection within past 6 month infection skin disease around target knee specific medical condition ( rheumatoid arthritis , hemiparesis , neoplasm , etc . ) would interfere assessment</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Knee osteoarthritis</keyword>
	<keyword>Hyaluronic acid</keyword>
	<keyword>Viscosupplementation</keyword>
</DOC>